Anti-human VEGF Antibody, Mouse Monoclonal
Product details
General Information
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.
Properties
| Pair Recommendation |
CLIA (Capture-Detection): 12A4-7 ~ 5F6-2 2B4-6 ~ 5F6-2 |
| Purity | >95%, determined by SDS-PAGE |
| Buffer Formulation | PBS, pH7.4. |
| Storage | Store it under sterile conditions at -20℃ to -80℃ upon receiving. Recommend to aliquot the protein into smaller quantities for optimal storage. |
Competitive Comparison
Order Information
| Product Name | Cat. No | Clone ID |
| VEGFA | AB0042-1 | 2B4-6 |
| AB0042-2 | 12A4-7 | |
| AB0042-3 | 5F6-2 |
Note: Bioantibody can customized quantities per your need.
Citations
1.Tammela T , Enholm B , Alitalo K , et al. The biology of vascular endothelial growth factors[J]. Cardiovascular Research, 2005, 65(3):550.
2.Wolfgang, Lieb, Radwan, et al. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.[J]. European heart journal, 2009.
